Source link : https://www.newshealth.biz/health-news/erenumab-reduces-flushing-and-erythema-in-rosacea/
In a small, nonrandomized controlled trial, the injectable calcitonin gene-related peptide (CGRP) inhibitor erenumab significantly reduced treatment-resistant flushing and erythema associated with rosacea. Skin-related quality-of-life (QOL) measures also improved, albeit modestly. The study was published in JAMA Dermatology on April 17. “The transient erythema of rosacea is one of the most challenging rosacea symptoms to […]
Author : News Health
Publish date : 2024-04-24 07:16:41
Copyright for syndicated content belongs to the linked Source.